A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age
一项评估Vi-DT伤寒结合疫苗多剂量和单剂量制剂在6个月至45岁健康菲律宾人群中免疫等效性和安全性的3期、多中心、随机、对照试验
期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2022.100484
Carlos, Josefina Cadorna; Tadesse, Birkneh Tilahun; Borja-Tabora, Charissa; Alberto, Edison; Ylade, Michelle C; Sil, Arijit; Kim, Deok Ryun; Ahn, Hyeon Seon; Yang, Jae Seung; Lee, Ji Yeon; Kim, Min Soo; Park, Jiwook; Kwon, Soo-Young; Kim, Hun; Yang, Seon-Young; Ryu, Ji-Hwa; Park, Hokeun; Shin, Jong-Hoon; Lee, Yoonyeong; Kim, Jerome H; Mojares, Zenaida Reynoso; Wartel, T Anh; Sahastrabuddhe, Sushant